The FDA has granted market clearance to Cedara Software's Web-enabled viewer, part of its Software for the Heart suite (HNN 10/18/00). The application enables clinicians to capture, retrieve, display, measure, and report on images acquired
The FDA has granted market clearance to Cedara Software's Web-enabled viewer, part of its Software for the Heart suite (HNN 10/18/00). The application enables clinicians to capture, retrieve, display, measure, and report on images acquired from multiple modalities (such as x-ray, echocardiography, and CT). The viewer supports both static and dynamic (cine) views and has a plug-in architecture, enabling integration of the viewer into other, third-party, products. The Canadian company plans to develop noncardiology applications for the viewer as well.
© 2000 Miller Freeman Inc.
12/13/00, Issue # 118, page 5.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.